Literature DB >> 27617404

Immortalization of human normal and NF1 neurofibroma Schwann cells.

Hua Li1, Lung-Ji Chang1, Debbie R Neubauer2, David F Muir2,3,4, Margaret R Wallace1,4,5.   

Abstract

Neurofibromas, which are benign Schwann cell tumors, are the hallmark feature in the autosomal dominant condition neurofibromatosis 1 (NF1) and are associated with biallelic loss of NF1 gene function. There is a need for effective therapies for neurofibromas, particularly the larger, plexiform neurofibromas. Tissue culture is an important tool for research. However, it is difficult to derive enriched human Schwann cell cultures, and most enter replicative senescence after 6-10 passages, impeding cell-based research in NF1. Through exogenous expression of human telomerase reverse transcriptase and murine cyclin-dependent kinase (mCdk4), normal (NF1 wild-type), neurofibroma-derived Schwann cells heterozygous for NF1 mutation, and neurofibroma-derived Schwann cells homozygous for NF1 mutation were immortalized, including some matched samples from the same NF1 patient. Initial experiments employed retroviral vectors, while subsequent work utilized lentiviral vectors carrying these genes because of improved efficiency. Expression of both transgenes was required for immortalization. Molecular and immunohistochemical analysis indicated that these cell lines are of Schwann cell lineage and have a range of phenotypes, many of which are consistent with their primary cultures. This is the first report of immortalization and detailed characterization of multiple human NF1 normal nerve and neurofibroma-derived Schwann cell lines, which will be highly useful research tools to study NF1 and other Schwann tumor biology and conditions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27617404     DOI: 10.1038/labinvest.2016.88

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  50 in total

Review 1.  Cell aging in vivo and in vitro.

Authors:  H Rubin
Journal:  Mech Ageing Dev       Date:  1997-10       Impact factor: 5.432

2.  Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group.

Authors:  F Mertens; P Dal Cin; I De Wever; C D Fletcher; N Mandahl; F Mitelman; J Rosai; A Rydholm; R Sciot; G Tallini; H van Den Berghe; R Vanni; H Willén
Journal:  J Pathol       Date:  2000-01       Impact factor: 7.996

3.  Human endothelial cell life extension by telomerase expression.

Authors:  J Yang; E Chang; A M Cherry; C D Bangs; Y Oei; A Bodnar; A Bronstein; C P Chiu; G S Herron
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

4.  An orthotopic xenograft model of intraneural NF1 MPNST suggests a potential association between steroid hormones and tumor cell proliferation.

Authors:  George Q Perrin; Hua Li; Lauren Fishbein; Susanne A Thomson; Min S Hwang; Mark T Scarborough; Anthony T Yachnis; Margaret R Wallace; Thomas H Mareci; David Muir
Journal:  Lab Invest       Date:  2007-09-17       Impact factor: 5.662

Review 5.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

6.  Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells.

Authors:  Arsene M Adon; Xiangbin Zeng; Mary K Harrison; Stacy Sannem; Hiroaki Kiyokawa; Philipp Kaldis; Harold I Saavedra
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

Review 7.  Advances in the treatment of neurofibromatosis-associated tumours.

Authors:  Andrew L Lin; David H Gutmann
Journal:  Nat Rev Clin Oncol       Date:  2013-08-13       Impact factor: 66.675

8.  Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis.

Authors:  Eric P Rahrmann; Branden S Moriarity; George M Otto; Adrienne L Watson; Kwangmin Choi; Margaret H Collins; Margaret Wallace; Beau R Webber; Colleen L Forster; Anthony E Rizzardi; Stephen C Schmechel; Nancy Ratner; David A Largaespada
Journal:  Am J Pathol       Date:  2014-05-13       Impact factor: 4.307

9.  Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation.

Authors:  A J Brenner; M R Stampfer; C M Aldaz
Journal:  Oncogene       Date:  1998-07-16       Impact factor: 9.867

10.  Efficient nuclear localization and immortalizing ability, two functions dependent on the adenovirus type 5 (Ad5) E1A second exon, are necessary for cotransformation with Ad5 E1B but not with T24ras.

Authors:  J L Douglas; M P Quinlan
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  28 in total

1.  Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.

Authors:  Annmarie Ramkissoon; Katherine E Chaney; David Milewski; Kyle B Williams; Rory L Williams; Kwangmin Choi; Adam Miller; Tanya V Kalin; Joseph G Pressey; Sara Szabo; Mohammad Azam; David A Largaespada; Nancy Ratner
Journal:  Clin Cancer Res       Date:  2019-04-01       Impact factor: 12.531

2.  Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1

Authors:  Julie A Mund; SuJung Park; Abbi E Smith; Yongzheng He; Li Jiang; Eric Hawley; Michelle J Roberson; Dana K Mitchell; Mohannad Abu-Sultanah; Jin Yuan; Waylan K Bessler; George Sandusky; Shi Chen; Chi Zhang; Steven D Rhodes; D Wade Clapp
Journal:  J Biol Chem       Date:  2020-05-29       Impact factor: 5.157

Review 3.  Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside.

Authors:  Justin Korfhage; David B Lombard
Journal:  Mol Cancer Res       Date:  2019-04-25       Impact factor: 5.852

4.  YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators.

Authors:  Sany Hoxha; Alyssa Shepard; Scott Troutman; Huitian Diao; Joanne R Doherty; Michalina Janiszewska; Robert M Witwicki; Matthew E Pipkin; William W Ja; Michael S Kareta; Joseph L Kissil
Journal:  Cancer Res       Date:  2020-05-14       Impact factor: 12.701

5.  The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor.

Authors:  Kathryn M Lemberg; Liang Zhao; Ying Wu; Vijayabhaskar Veeravalli; Jesse Alt; Joanna Marie H Aguilar; Ranjeet P Dash; Jenny Lam; Lukáš Tenora; Chabely Rodriguez; Michael T Nedelcovych; Cory Brayton; Pavel Majer; Jaishri O Blakeley; Rana Rais; Barbara S Slusher
Journal:  Mol Cancer Ther       Date:  2019-10-08       Impact factor: 6.261

6.  EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer.

Authors:  Michel Wassef; Armelle Luscan; Setareh Aflaki; Dina Zielinski; Pascal W T C Jansen; H Irem Baymaz; Aude Battistella; Carole Kersouani; Nicolas Servant; Margaret R Wallace; Pierre Romero; Olivier Kosmider; Pierre-Alexandre Just; Mikaël Hivelin; Sébastien Jacques; Anne Vincent-Salomon; Michiel Vermeulen; Michel Vidaud; Eric Pasmant; Raphaël Margueron
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-13       Impact factor: 11.205

Review 7.  Human stem cell modeling in neurofibromatosis type 1 (NF1).

Authors:  Michelle L Wegscheid; Corina Anastasaki; David H Gutmann
Journal:  Exp Neurol       Date:  2017-04-06       Impact factor: 5.330

8.  Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening.

Authors:  Janice M Kraniak; Anita Chalasani; Margaret R Wallace; Raymond R Mattingly
Journal:  Exp Neurol       Date:  2017-10-19       Impact factor: 5.330

9.  Neurofibromin Deficiency and Extracellular Matrix Cooperate to Increase Transforming Potential through FAK-Dependent Signaling.

Authors:  Andrea Errico; Anna Stocco; Vincent M Riccardi; Alberto Gambalunga; Franco Bassetto; Martina Grigatti; Amedeo Ferlosio; Gianluca Tadini; Debora Garozzo; Stefano Ferraresi; Andrea Trevisan; Sandra Giustini; Andrea Rasola; Federica Chiara
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

10.  Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.

Authors:  Carlos Sanchez-Martin; Daniela Menon; Elisabetta Moroni; Mariarosaria Ferraro; Ionica Masgras; Justin Elsey; Jack L Arbiser; Giorgio Colombo; Andrea Rasola
Journal:  Antioxid Redox Signal       Date:  2020-06-23       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.